Plato Investment Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.68M Buy
6,919
+1,018
+17% +$430K 0.15% 147
2026
Q1
$2.79M Buy
5,901
+1,993
+51% +$1M 0.19% 121
2025
Q4
$1.83M Buy
3,908
+22
+0.6% +$10.2K 0.12% 182
2025
Q3
$1.64M Hold
3,886
– – 0.11% 195
2025
Q2
$1.48M Buy
3,886
+2
+0.1% +$721 0.11% 192
2025
Q1
$1.36M Sell
3,884
-1,144
-23% -$368K 0.11% 196
2024
Q4
$1.51M Buy
5,028
+258
+5% +$90.2K 0.11% 189
2024
Q3
$1.94M Buy
4,770
+1,624
+52% +$595K 0.16% 154
2024
Q2
$1.01M Buy
3,146
+6
+0.2% +$1.95K 0.09% 205
2024
Q1
$1.05M Buy
3,140
+2,730
+666% +$834K 0.11% 201
2023
Q4
$111K Buy
+410
New +$101K 0.14% 147

Other funds holding HCA

Plato Investment Management's HCA Position: Q2 2026 in Review

Plato Investment Management increased its HCA Healthcare (HCA) stake by 17% in Q2 2026, buying an estimated $430K and bringing the position to 6,919 shares worth $2.68M. The position accounts for 0.15% of the portfolio, ranked #147.

Plato Investment Management first reported a position in HCA in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.79M in Q1 2026. 1,342 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Plato Investment Management held 6,919 shares of HCA Healthcare worth $2.68M as of Q2 2026.
  • Plato Investment Management bought 1,018 HCA Healthcare shares in Q2 2026, an estimated $430K.
  • HCA Healthcare made up 0.15% of Plato Investment Management's portfolio in Q2 2026, its #147 holding.
  • Plato Investment Management first reported a position in HCA Healthcare in Q4 2023 and has held it in 11 quarters since.
  • Plato Investment Management's HCA Healthcare position peaked at $2.79M in Q1 2026.
  • 1,342 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Plato Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.